Abarca Health Launches AI Tools for Coverage Reviews
The new software suite helps pharmacy benefit managers automate prior authorization processes and reduce administrative work.
Updated on Oct. 26, 2026 in Healthcare
Live Poll
Do you trust artificial intelligence to handle medical coverage and authorization decisions for patients?
Abarca Health has launched Darwin H/I, an AI-powered software update designed to streamline prior authorization and coverage determinations for healthcare operators. This release follows the company’s recent business combination with pharmacy benefit manager LucyRx, which concluded in August 2026.
Why it matters
The integration of these AI tools aims to reduce the administrative burden of coverage reviews by connecting operational data across health plans and providers. For operators managing drug benefits, this shift reflects an industry-wide effort to accelerate pharmacy workflows while maintaining clinical oversight.
The combined entity of Abarca Health and LucyRx now serves more than 9 million members, an increase from 7.5 million served by Abarca earlier this year. The firm currently manages $14 billion in annual prescription drug spending.
The players
Abarca Health
A Puerto Rico-based company that manages pharmacy benefits and prescription drug spending for health plans.
LucyRx
A pharmacy benefit manager that recently completed a business combination with Abarca Health.
The details
Darwin H/I introduces three core tools: Darwin Context, Charlie, and Darwin PAth. Darwin PAth is specifically engineered to simplify prior authorization processes by automating data synthesis while retaining final decision authority for clinicians. These tools integrate directly into the existing software platforms already utilized by health plans and providers.
Timeline
August 20, 2026: Abarca Health and LucyRx completed their business combination.
October 26, 2026: Abarca Health officially launched the Darwin H/I software system.
Market Landscape
The deployment of Darwin H/I follows a pattern set by industry-wide efforts to meet CMS electronic prior authorization mandates. It signals a move toward using AI to automate the administrative back-and-forth that has historically slowed pharmacy benefit delivery.
Operators in the pharmacy benefit space should monitor how integrated AI tools like Darwin PAth influence authorization response times and staffing requirements. Assess your current platform against these new automated capabilities to determine if administrative bottlenecks can be similarly reduced.
The takeaway
The use of AI in prior authorization is moving from a theoretical optimization to a live operational tool. Operators should track the performance of these tools against current manual throughput metrics to justify potential future platform migrations.
What happens next
Abarca Health plans to expand the Darwin suite in the future with the release of Darwin Companion to update pharmacy portals and Darwin Predict to forecast prescription drug spending trends.
Further reading
Learn more about evolving Healthcare technologies and their impact on clinical operations.
Source note: This article includes information reported by News is My Business.
Live Poll
Do you trust artificial intelligence to handle medical coverage and authorization decisions for patients?
